<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC on</title><link>https://www.physician.tw/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/</link><description>Recent content in Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC on</description><generator>Hugo -- gohugo.io</generator><language>zh-tw</language><managingEditor>1izard@duck.com (林協霆醫師 Hsieh-Ting Lin M.D.)</managingEditor><webMaster>1izard@duck.com (林協霆醫師 Hsieh-Ting Lin M.D.)</webMaster><copyright>Hsieh-Ting All rights reserved</copyright><lastBuildDate>Wed, 01 Nov 2023 00:00:00 +0000</lastBuildDate><atom:link href="https://www.physician.tw/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/rss.xml" rel="self" type="application/rss+xml"/></channel></rss>